166 related articles for article (PubMed ID: 22670674)
1. MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts.
Han KY; Fahd DC; Tshionyi M; Allemann N; Jain S; Chang JH; Azar DT
Protein Pept Lett; 2012 Dec; 19(12):1334-9. PubMed ID: 22670674
[TBL] [Abstract][Full Text] [Related]
2. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.
Onguchi T; Han KY; Chang JH; Azar DT
Am J Pathol; 2009 Apr; 174(4):1564-71. PubMed ID: 19264910
[TBL] [Abstract][Full Text] [Related]
3. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
Azar DT
Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.
Chang JH; Huang YH; Cunningham CM; Han KY; Chang M; Seiki M; Zhou Z; Azar DT
Surv Ophthalmol; 2016; 61(4):478-97. PubMed ID: 26647161
[TBL] [Abstract][Full Text] [Related]
5. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis.
Mimura T; Han KY; Onguchi T; Chang JH; Kim TI; Kojima T; Zhou Z; Azar DT
J Vasc Res; 2009; 46(6):541-50. PubMed ID: 19571574
[TBL] [Abstract][Full Text] [Related]
6. MT1-MMP cleavage of the antiangiogenic proteoglycan decorin: role in corneal angiogenesis.
Mimura T; Chang JH; Kim TI; Onguchi T; Kojima T; Sakimoto T; Azar DT
Cornea; 2011 Oct; 30 Suppl 1(Suppl 1):S45-9. PubMed ID: 21912230
[TBL] [Abstract][Full Text] [Related]
7. Novel aspects of corneal angiogenic and lymphangiogenic privilege.
Ellenberg D; Azar DT; Hallak JA; Tobaigy F; Han KY; Jain S; Zhou Z; Chang JH
Prog Retin Eye Res; 2010 May; 29(3):208-48. PubMed ID: 20100589
[TBL] [Abstract][Full Text] [Related]
8. Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis.
Han KY; Chang JH; Lee H; Azar DT
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3313-22. PubMed ID: 27327585
[TBL] [Abstract][Full Text] [Related]
9. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice.
Kure T; Chang JH; Kato T; Hernández-Quintela E; Ye H; Lu PC; Matrisian LM; Gatinel D; Shapiro S; Gosheh F; Azar DT
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):137-44. PubMed ID: 12506066
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-Based Characterization of the Effects of MMP14 on the Protein Content of Exosomes from Corneal Fibroblasts.
Han KY; Chang JH; Azar DT
Protein Pept Lett; 2020; 27(10):979-988. PubMed ID: 32268857
[TBL] [Abstract][Full Text] [Related]
12. VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.
Oliveira HB; Sakimoto T; Javier JA; Azar DT; Wiegand SJ; Jain S; Chang JH
Eur J Ophthalmol; 2010; 20(1):48-54. PubMed ID: 19882518
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.
Park BC; Thapa D; Lee JS; Park SY; Kim JA
J Pharmacol Sci; 2009 Sep; 111(1):1-12. PubMed ID: 19763043
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
[TBL] [Abstract][Full Text] [Related]
15. Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation.
Ispanovic E; Serio D; Haas TL
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C600-10. PubMed ID: 18562481
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.
Ebrahem Q; Chaurasia SS; Vasanji A; Qi JH; Klenotic PA; Cutler A; Asosingh K; Erzurum S; Anand-Apte B
Am J Pathol; 2010 Jan; 176(1):496-503. PubMed ID: 19948826
[TBL] [Abstract][Full Text] [Related]
17. MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis.
Wong HL; Jin G; Cao R; Zhang S; Cao Y; Zhou Z
Nat Commun; 2016 Mar; 7():10824. PubMed ID: 26926389
[TBL] [Abstract][Full Text] [Related]
18. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.
Barnes RH; Akama T; Öhman MK; Woo MS; Bahr J; Weiss SJ; Eitzman DT; Chun TH
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735290
[TBL] [Abstract][Full Text] [Related]
19. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
Kajanne R; Miettinen P; Mehlem A; Leivonen SK; Birrer M; Foschi M; Kähäri VM; Leppä S
J Cell Physiol; 2007 Aug; 212(2):489-97. PubMed ID: 17348021
[TBL] [Abstract][Full Text] [Related]
20. MMP14 Cleavage of VEGFR1 in the Cornea Leads to a VEGF-Trap Antiangiogenic Effect.
Han KY; Dugas-Ford J; Lee H; Chang JH; Azar DT
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5450-6. PubMed ID: 26284550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
